Diabetes mellitus Posts - Page 10 of 108 on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Can oat bran improve gestational diabetes?

Can oat bran improve gestational diabetes?

Posted by on May 16, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at whether oat bran consumption benefited women with diabetes during pregnancy. It found that adding oat bran to the recommended diet improved blood sugar levels in these women. Some background Gestational diabetes (GD) is a common pregnancy-related health condition. It involves high levels of glucose (sugar)...

Read More

Does lipoprotein A level affect kidney disease in patients with type 2 diabetes?

Does lipoprotein A level affect kidney disease in patients with type 2 diabetes?

Posted by on May 9, 2021 in Diabetes mellitus | 0 comments

In a nutshell This review looked at levels of lipoprotein A (LpA), in people with type 2 diabetes (T2D). It found that people with higher levels LpA in their blood were more likely to have kidney disease. Some background For people living with T2D, an important consideration is managing long-term health and preventing complications. T2D involves...

Read More

The effect of adding henagliflozin treatment to metformin in patients with type 2 diabetes.

The effect of adding henagliflozin treatment to metformin in patients with type 2 diabetes.

Posted by on May 9, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness of adding henagliflozin (SHR3824) to metformin (Glucophage) in patients with uncontrolled type 2 diabetes (T2D). The authors concluded that the addition of 5 mg or 10 mg of henagliflozin to metformin was well-tolerated and effective in these patients.  Some background...

Read More

Can ertugliflozin improve diabetes and blood pressure in patients who have heart disease?

Can ertugliflozin improve diabetes and blood pressure in patients who have heart disease?

Posted by on May 6, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the ertugliflozin (Steglatro) for patients with type 2 diabetes (T2D) and heart disease. It found that ertugliflozin improved both blood glucose control, body weight, and blood pressure. Some background T2D is a condition in which the levels of glucose (sugar) in the blood are too high. T2D is related to...

Read More

Which type of insulin is best for avoiding hypoglycemia in patients with high risk type 2 diabetes?

Which type of insulin is best for avoiding hypoglycemia in patients with high risk type 2 diabetes?

Posted by on Apr 30, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the risk of hypoglycemia (dangerously low blood glucose levels) for insulin glargine 300 U/ml (Gla-300; Toujeo) and standard-of-care basal insulin (SOC-BI) at patients with type 2 diabetes (T2D) with risk factors for hypoglycemia. It found that Gla-300 was associated with a lower risk of hypoglycemia than...

Read More

Evaluating semaglutide at a higher dose in adults with overweight or obesity and type 2 diabetes.

Evaluating semaglutide at a higher dose in adults with overweight or obesity and type 2 diabetes.

Posted by on Apr 24, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effect of two doses of semaglutide (Ozempic), 2.4 mg and 1.0 mg to a placebo, given once weekly subcutaneously (sc; injected under the skin) to adults with overweight or obesity and type 2 diabetes (T2D). The authors concluded that patients treated with 2.4 mg of semaglutide once weekly showed a higher...

Read More

Can using ultra-rapid lispro in patients with type 1 diabetes using subcutaneous insulin infusion improve glucose control after meals?

Can using ultra-rapid lispro in patients with type 1 diabetes using subcutaneous insulin infusion improve glucose control after meals?

Posted by on Apr 11, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of ultra-rapid lispro (URLi; LyumjevTM) to lispro (Humalog) in patients with type 1 diabetes (T1D) on continuous subcutaneous insulin infusion (CSII). The authors concluded that URLi was similarly effective and provided improved postprandial glucose (PPG) control with reduced hypoglycemia in...

Read More